Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aluminum Monostearate
2. Aluminum Tristearate
3. Ammonium Stearate
4. Calcium Stearate
5. Magnesium Stearate
6. Octadecanoic Acid
7. Sodium Stearate
8. Stearic Acid
1. 557-05-1
2. Zinc Distearate
3. Zinc Octadecanoate
4. Octadecanoic Acid, Zinc Salt
5. Metallac
6. Stearates
7. Zn Stearate
8. Talculin Z
9. Stavinor Zn-e
10. Zinc Bisstearate
11. Metasap 576
12. Zinc Stearate W. S
13. Stearic Acid, Zinc Salt
14. Zinc Stearate [usp]
15. Stearic Acid Zinc Salt
16. H92e6qa4fv
17. Zinc Stearate (usp)
18. Hydense
19. Hytech
20. Mathe
21. Coad
22. Zinci Stearas
23. Zink Distearat
24. Unichem Zs
25. Zincum Stearinicum
26. 144188-98-7
27. Dibasic Zinc Stearate
28. Petrac Zn-41
29. Caswell No. 926
30. Synpro Stearate (van)
31. Witco Zinc Stearate Usp
32. Hsdb 212
33. Nsc-25957
34. Zinc Distearate, Pure
35. Einecs 209-151-9
36. Nsc 25957
37. Zinc Stearate, Total Dust
38. Unii-h92e6qa4fv
39. Epa Pesticide Chemical Code 077002
40. Zincstearate
41. Ai3-00388
42. Znst
43. Zinc;octadecanoate
44. Zinc Stearate, Respirable Fraction
45. Zinc Dioctadecanoate
46. Zinc(ii) Stearate
47. Zinc Stearate Spl
48. Zinc Stearate Tcg
49. Zinc Stearate Tcp
50. Einecs 257-363-5
51. Octadecanoic Acid, Zinc Salt, Basic
52. Octadecanoic Acid, Zinc Salt (2:1)
53. Lubimax Zinc Stearate
54. Rashayan Zinc Stearate
55. Starbld0000624
56. Ec 209-151-9
57. Schembl4923
58. Zinc Stearate [ii]
59. Zinc Stearate [mi]
60. Zinc Stearate [hsdb]
61. Zinc Stearate [inci]
62. Zinc Stearate [vandf]
63. Zinc Stearate [mart.]
64. Zinc Stearate [usp-rs]
65. Zinc Stearate [who-dd]
66. Dtxsid7027209
67. Zinc Stearate, Zno 12.5-14%
68. Mfcd00013031
69. Zinc Stearate [ep Monograph]
70. Zinc Stearate [usp Monograph]
71. Akos015915230
72. 51731-04-5
73. Ft-0645152
74. D06370
75. A830766
76. Q204923
| Molecular Weight | 632.3 g/mol |
|---|---|
| Molecular Formula | C36H70O4Zn |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 30 |
| Exact Mass | 630.456552 g/mol |
| Monoisotopic Mass | 630.456552 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 196 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Zinc stearate is a mild antiseptic and astringent, and it has been used as a local soothing application for inflammatory and irritating skin diseases.
Cosmetic Ingredient Expert Review Panel; Final Report on the Safety Assessment of Lithium Stearate, Aluminum Distearate, Aluminum Stearate, Aluminum Tristearate, Ammonium Stearate, Calcium Stearate, Magnesium Stearate, Potassium Stearate, Sodium Stearate and Zinc Stearate. Journal of the American College of Toxicology 1 (2): 143-77 (1982).
Zinc stearate is primarily used in pharmacuetical formulations as a lubricant in tablet and capsule manufacture at concentrations up to 1.5% w/w.
Rowe, R.C., Sheskey, P.J., Quinn, M.E.; (Eds.), Handbook of Pharmaceutical Excipients 6th edition Pharmaceutical Press, London, England 2009, p. 793
In dental cement
Kirk-Othmer Encyclopedia of Chemical Technology. 3rd ed., Volumes 1-26. New York, NY: John Wiley and Sons, 1978-1984., p. 7: 467 (1979)
... Its use as dusting powder for infants is not recommended.
American Hospital Formulary Service. Volumes I and II. Washington, DC: American Society of Hospital Pharmacists, to 1984., p. 84:24
In humans with no excessive intake of zinc, the body burden half-time of absorbed radio-labelled zinc has been observed to range from 162 to 500 days. After parenteral administration of 65Zn2+, half-times ranged from 100 to 500 days. /Zinc ions/
European Chemicals Bureau; Risk Assessment Report on Zinc Distearate, CAS-No.: 557-05-1, 91051-01-3. EINECS-No.: 209-151-9, 293-049-4. Part II - Human Health p.37 (2004). Available from, as of March 24, 2011: https://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/zincdistearatereport074.pdf
Within certain limits, mammals can maintain the total body zinc and the physiologically required levels of zinc in the various tissues constant, both at low and high dietary zinc intakes. The sites of regulation of zinc metabolism are: absorption of Zn2+ from the gastrointestinal tract, excretion of zinc in urine, exchange of zinc with erythrocytes, release of zinc from tissue, and secretion of zinc into the gastrointestinal tract. Regulation of gastrointestinal absorption and gastrointestinal secretion probably contributes the most to zinc homeostasis. /Zinc ions/
European Chemicals Bureau; Risk Assessment Report on Zinc Distearate, CAS-No.: 557-05-1, 91051-01-3. EINECS-No.: 209-151-9, 293-049-4. Part II - Human Health p.38 (2004). Available from, as of March 24, 2011: https://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/zincdistearatereport074.pdf
Zinc is mostly bound to organic ligands rather than free in solution as a cation. Zinc is found in diffusible and non-diffusible forms in the blood and about 66% of the diffusible form of zinc in the plasma is freely exchangeable and loosely bound to albumin. A small amount of the non-diffusible form of zinc is tightly bound to 2-macroglobulin in the plasma and is not freely exchangeable with other zinc ligands. Zinc is incorporated into and dissociated from alpha2-macroglobulin only in the liver. /Zinc ions/
European Chemicals Bureau; Risk Assessment Report on Zinc Distearate, CAS-No.: 557-05-1, 91051-01-3. EINECS-No.: 209-151-9, 293-049-4. Part II - Human Health p.36 (2004). Available from, as of March 24, 2011: https://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/zincdistearatereport074.pdf
For zinc, whole body: 162-500 days; [TDR, p. 1245]
TDR - Ryan RP, Terry CE, Leffingwell SS (eds). Toxicology Desk Reference: The Toxic Exposure and Medical Monitoring Index, 5th Ed. Washington DC: Taylor & Francis, 1999., p. 1245
In humans with no excessive intake of zinc, the body burden half-time of absorbed radio-labelled zinc has been observed to range from 162 to 500 days. After parenteral administration of 65Zn2+, half-times ranged from 100 to 500 days. /Zinc ions/
European Chemicals Bureau; Risk Assessment Report on Zinc Distearate, CAS-No.: 557-05-1, 91051-01-3. EINECS-No.: 209-151-9, 293-049-4. Part II - Human Health p.37 (2004). Available from, as of March 24, 2011: https://ecb.jrc.ec.europa.eu/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/zincdistearatereport074.pdf
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Zinc Stearate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zinc Stearate, including repackagers and relabelers. The FDA regulates Zinc Stearate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zinc Stearate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zinc Stearate supplier is an individual or a company that provides Zinc Stearate active pharmaceutical ingredient (API) or Zinc Stearate finished formulations upon request. The Zinc Stearate suppliers may include Zinc Stearate API manufacturers, exporters, distributors and traders.
click here to find a list of Zinc Stearate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zinc Stearate DMF (Drug Master File) is a document detailing the whole manufacturing process of Zinc Stearate active pharmaceutical ingredient (API) in detail. Different forms of Zinc Stearate DMFs exist exist since differing nations have different regulations, such as Zinc Stearate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zinc Stearate DMF submitted to regulatory agencies in the US is known as a USDMF. Zinc Stearate USDMF includes data on Zinc Stearate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zinc Stearate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zinc Stearate suppliers with USDMF on PharmaCompass.
A Zinc Stearate CEP of the European Pharmacopoeia monograph is often referred to as a Zinc Stearate Certificate of Suitability (COS). The purpose of a Zinc Stearate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zinc Stearate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zinc Stearate to their clients by showing that a Zinc Stearate CEP has been issued for it. The manufacturer submits a Zinc Stearate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zinc Stearate CEP holder for the record. Additionally, the data presented in the Zinc Stearate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zinc Stearate DMF.
A Zinc Stearate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zinc Stearate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zinc Stearate suppliers with CEP (COS) on PharmaCompass.
Zinc Stearate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zinc Stearate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zinc Stearate GMP manufacturer or Zinc Stearate GMP API supplier for your needs.
A Zinc Stearate CoA (Certificate of Analysis) is a formal document that attests to Zinc Stearate's compliance with Zinc Stearate specifications and serves as a tool for batch-level quality control.
Zinc Stearate CoA mostly includes findings from lab analyses of a specific batch. For each Zinc Stearate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zinc Stearate may be tested according to a variety of international standards, such as European Pharmacopoeia (Zinc Stearate EP), Zinc Stearate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zinc Stearate USP).
LOOKING FOR A SUPPLIER?
